abstract |
The present invention relates to 2-phenyl-6-aminocarbonyl-pyrimidine derivatives and platelet aggregation including peripheral blood vessels, visceral blood vessels, liver blood vessels, renal blood vessels, cardiovascular, cerebrovascular diseases and thrombosis in humans or other mammals. It relates to the use of these compounds as P2Y 12 receptor antagonists in the treatment and / or prevention of conditions related to. [Selection figure] None |